Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1Phase 2/3 1

Status

Unknown 4Completed 4Recruiting 2Terminated 1

Sponsor Class

OTHER 4INDUSTRY 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Breast 4

Conditions

Breast Neoplasms 4

Interventions

Cyclophosphamide 956Radiotherapy 847Cisplatin 757Gemcitabine 657Carboplatin 603Docetaxel 598Paclitaxel 585Bevacizumab 580Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 424Etoposide 411Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 328Leucovorin 305Nivolumab 296fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 280Peripheral Blood Stem Cell Transplantation 279Blood Specimen Collection 279Methotrexate 276Lenalidomide 276Cetuximab 270

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × OTHER × EC regimen × Clear all
NCT05128617 2023-06-08

PROTECT-06

Institut de cancérologie Strasbourg Europe

Completed
20 enrolled
Breast

Breast Neoplasms

NCT00567554 2016-02-10

GeparQuinto

GBG Forschungs GmbH

Phase 3 Completed
2,600 enrolled
Breast

Breast Neoplasms

NCT01204437 2016-02-10

ICE-II

GBG Forschungs GmbH

Phase 2/3 Completed
400 enrolled
Breast

Breast Neoplasms

NCT01199432 2015-06-10

Comparative Efficiency of Three Regimen, CEFci, CEF and EC as Neoadjuvant Chemotherapy for Primary Breast Cancer

Peking University

Phase 4 Completed
501 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡